Clinical Trial Update: Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites [Phase 1]

View source ↗

Summary

Phase 1 absorption, distribution, metabolism, and excretion study of [14C]-labeled BIA 9-1067 and metabolites with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-01-09